Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
158.07
+12.45 (8.55%)
At close: Sep 17, 2026, 4:00 PM EDT
157.82
-0.25 (-0.16%)
After-hours: Sep 17, 2026, 5:16 PM EDT
Moderna Employees
Moderna had 4,700 employees as of December 31, 2025. The number of employees decreased by 1,100 or -18.97% compared to the previous year.
Employees
4,700
Change (1Y)
-1,100
Growth (1Y)
-18.97%
Revenue / Employee
$474,043
Profits / Employee
-$670,426
Market Cap
63.11B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | -1,100 | -18.97% |
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
MRNA News
- 3 hours ago - Moderna stock rises 8%: can it continue its cancer vaccine success rally? - Invezz
- 3 days ago - Moderna's AI-Built Cancer Vaccine Clears Phase 3 With Merck - PYMNTS
- 3 days ago - Moderna Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 8 days ago - AI & Robotics in 2026: 16 Recent Developments for Investors - ETF Trends
- 12 days ago - Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off. - Business Insider
- 14 days ago - Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets - FXEmpire
- 14 days ago - Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense - Barrons
- 14 days ago - Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating - Barrons